These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3037614)

  • 1. The ACTH stimulation test in depression.
    Amsterdam JD; Lucki I; Winokur A
    Psychiatr Med; 1985; 3(2):91-100. PubMed ID: 3037614
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the ACTH suppression test and dexamethasone suppression test in depressed patients.
    Demisch K; Demisch L; Bochnik HJ; Schulz F
    Am J Psychiatry; 1983 Nov; 140(11):1511-2. PubMed ID: 6312817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The dexamethasone suppression test in affective disorders. A review].
    Charles G; Wilmotte J; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):349-62. PubMed ID: 6299064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and postdexamethasone plasma ACTH and beta-endorphin levels in endogenous and nonendogenous depression.
    Rupprecht R; Barocka A; Beck G; Schrell U; Pichl J
    Biol Psychiatry; 1988 Mar; 23(5):531-5. PubMed ID: 2830921
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTH and the dexamethasone suppression test in depression.
    Nasr SJ; Rodgers C; Pandey G; Altman EG; Gaviria FM; Davis JM
    Biol Psychiatry; 1983 Sep; 18(9):1069-73. PubMed ID: 6315089
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of depressive relapse in remitted bipolar patients using corticotrophin-releasing hormone challenge test.
    Vieta E; Gasto C; Martinez de Osaba MJ; Nieto E; Canto TJ; Otero A; Vallejo J
    Acta Psychiatr Scand; 1997 Mar; 95(3):205-11. PubMed ID: 9111853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates of the TRH infusion test in primary depression.
    Kirstein L; Gold MS; Extein I; Martin D; Pottash AL
    J Clin Psychiatry; 1982 May; 43(5):191-4. PubMed ID: 6804446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of ACTH and prolactin in the dexamethasone suppression test.
    Risch SC; Janowsky DS; Judd LL; Gillin JC; Mott MA; Rausch JL; Huey L
    Acta Psychiatr Scand; 1987 Nov; 76(5):535-40. PubMed ID: 2829509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological markers for endogenous depression in series and parallel.
    Feinberg M; Carroll BJ
    Biol Psychiatry; 1984 Jan; 19(1):3-11. PubMed ID: 6704459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thyrotropin releasing hormone stimulation test: a review.
    Sternbach H; Gerner RH; Gwirtsman HE
    J Clin Psychiatry; 1982 Jan; 43(1):4-6. PubMed ID: 6798028
    [No Abstract]   [Full Text] [Related]  

  • 12. CRH challenge test in anxious depression.
    Meller WH; Kathol RG; Samuelson SD; Gehris TL; Carroll BT; Pitts AF; Clayton PJ
    Biol Psychiatry; 1995 Mar; 37(6):376-82. PubMed ID: 7772646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationships of historically defined subtypes of depression to ACTH and cortisol levels in depression: preliminary study.
    Winokur G; Pfohl B; Sherman B
    Biol Psychiatry; 1985 Jul; 20(7):751-7. PubMed ID: 2988656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The overnight dexamethasone suppression test: clinical and theoretical review.
    Gwirtsman H; Gerner RH; Sternbach H
    J Clin Psychiatry; 1982 Aug; 43(8):321-7. PubMed ID: 7047505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety/depression: current management and future directions. Biologic markers and treatment response.
    Carroll BJ
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):30-40. PubMed ID: 6348035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol suppression index: a new approach to interpreting the DST in depression.
    Bernstein JP; Chung SY; Avila KS
    J Clin Psychiatry; 1982 Dec; 43(12):476-8. PubMed ID: 7161249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL; Newbury N
    J Clin Psychiatry; 1985 Jun; 46(6):217-21. PubMed ID: 3922959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Re-analysis of the diagnostic significance of the dexamethasone suppression test in depression].
    Shen QJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):279-83. PubMed ID: 3833512
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroendocrine evaluation of depression in borderline patients.
    Carroll BJ; Greden JF; Feinberg M; Lohr N; James NM; Steiner M; Haskett RF; Albala AA; DeVigne JP; Tarika J
    Psychiatr Clin North Am; 1981 Apr; 4(1):89-99. PubMed ID: 7232239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.